Pine Labs shares list at 9.5% premium to IPO price on BSE, beat grey market expectations

The stock then erased some gains to close at Rs 251.80 apiece on its market debut day. This marks a 14 percent rise from the IPO price of Rs 221 apiece. The stock's market capitalisation at the end of the debut day stood at Rs 28,914 crore.

Pine Labs IPO GMP:

Ahead of listing, the shares of the company were trading with 2.49 percent grey market premium (GMP) over the IPO price, according to data on Investorgain. The GMP has increased from the 0.45 percent quoted by the site on the day the IPO closed for public bidding, but is less than the 16 percent quoted earlier this month.

According to IPO Watch, the shares of the company were trading with 2.26 percent GMP over the issue price in the grey market, ahead of listing.

About Pine Labs IPO:

The public issue opened on November 7 and closed on November 11. The total issue size is estimated at Rs 3,900 crore. This includes a fresh issue of shares worth Rs 2,080 crore, and an offer-for-sale of 8.23 crore equity shares by key investors including Peak XV Partners, Macritchie Investments, Madison India, Mastercard, and PayPal.

Pine Labs, based out of Noida, operates across in-store point-of-sale terminals, online payment gateways, and prepaid and gift card solutions, serving millions of merchants globally.

The price band for the IPO was set at Rs 210-221 per share, valuing the company at approximately Rs 25,377 crore at the upper end. Investors could bid for a minimum of 67 shares, requiring an investment of Rs 14,807 at the upper price band and in multiples thereafter.

Pine Labs share listing: Should you buy, sell or hold?

Pine Labs has made a splash in the IPO market, listing at a premium and signalling renewed investor confidence in India’s fintech story, said Jickson Sajee, Research Analyst, INVasset PMS.

The analyst however advised some some caution. "While the revenue growth and first-profit milestone are positives, the IPO values the business aggressively relative to peers — implied P/E multiples run into the thousands if annualised from Q1 profits. Pine Labs also cut its IPO size: existing shareholders trimmed their offer by 44% and the fresh issue by 20%, reflecting the management’s willingness to reduce dilution. Major backers such as PayPal and Mastercard, which had invested when valuations were much lower, now sit on significant paper gains post-listing," he said.

Sajee said that for long-term investors, the call turns on execution - accelerating device rollouts, deepening merchant relationships, and converting scale into sustained free cash flow will determine whether the stock justifies its premium or becomes a cautionary tale of hopes priced ahead of proof.

Investors will have to carefully evaluate two things, profitability visibility and competitive intensity from UPI-led innovations, said Siddharth Maurya, Founder & Managing Director, Vibhavangal Anukulakara. "The success of the IPO will lie in whether the valuation meaningfully reflects Pine Labs' shift toward subscription-led and omnichannel revenue. If execution stays strong, Pine Labs could emerge as one of India's few scalable fintech platforms. But for long-term investors, it is not brand strength that should attract them, but rather the fundamentals," he added.

Prashanth Tapse, Senior Vice President (Research) at Mehta Equities, said the IPO appeared "slightly priced on the higher side," which was reflected in the subscription numbers. "The Employees’ category witnessed the strongest response with 7.7 times subscription, followed by Qualified Institutional Buyers (excluding anchors) at 4 times, while other investor segments showed muted interest," he said.

"Considering Pine Labs’ leadership in its segment and focus on technology-driven, high-margin solutions, we recommend that only risk-taking investors hold the stock with a long-term view. New investors may consider waiting for post-listing corrections as a potential entry point," he said.

The challenge for Pine Labs now lies in proving the durability of the momentum—sustaining revenue growth, delivering clean operating profits, and scaling its lending and SaaS verticals alongside its core payments business, said Harshal Dasani, Business Head, INVasset PMS. "If the profit trajectory continues, Pine Labs’ debut could redefine how India’s fintechs balance growth with disciplined profitability in public markets," he added.

"Despite the strong debut, investors remain cautious because of competitive intensity in fintech/merchant commerce, regulatory-risk in payments, and the need to deliver scaled profitability. The IPO attracted meaningful institutional participation, supported by expectations of continued growth in digital-payments adoption, merchant value-added services expansion, and improved operating leverage. Investors/traders allotted shares may consider booking part of the gain and holding the remainder for the medium to long term, with a stop-loss of 200," said Shivani Nyati, Head of Wealth at Swastika Investmart Ltd.

Follow all IPO news here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.